Latest news
Long Shortz with Neurizon Therapeutics: Milestones stack up for ALS program - NT NewsNT News · Tue, 04 Aug 2026 16:07:00 GMTNeurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon secures up to $17.5 million in non-dilutive R&D financing - BiotechDispatchBiotechDispatch · Mon, 03 Aug 2026 23:09:40 GMTEnterprise value to revenue forward of Neurizon Therapeutics Limited – ASX:NUZ - TradingViewTradingView · Sat, 01 Aug 2026 04:18:15 GMTNUZ:ASX Announcement - Neurizon Enters Strategic R&D Financing Facility - 31 Jul 2026 - Market IndexMarket Index · Fri, 31 Jul 2026 09:58:07 GMTNeurizon Therapeutics Secures $17.5 Million Non-Dilutive R&D Funding Facility with Dare Capital - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Secures Up to $17.5 Million Non-Dilutive R&D Financing Facility with Dare Capital - kalkine.com.aukalkine.com.au · Fri, 31 Jul 2026 07:00:00 GMTNeurizon progression potential breakthrough in ALS as NUZ-001 advances toward readout - BiotechDispatchBiotechDispatch · Wed, 29 Jul 2026 05:59:43 GMT